Electricity is the currency of the brain

Harnessing the brain’s restorative power

Electricity is the new medicine

01 02 03
Mission & Vision

We’re advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.

Our CEO, Brent Vaughan speaks about the promise of neuromodulation to improve the lives of millions of Alzheimer’s patients.

Our Novel Platform

Introducing our novel platform for neurodegenerative disease

Our investigational medical device delivers non-invasive neuromodulation with the potential to improve outcomes in a range of neurodegenerative diseases, including Alzheimer’s disease.

Home platform card
Our Pipeline

Leveraging our platform across multiple neurodegenerative diseases.



Alzheimer’s Disease


Mild Cognitive Impairment


Parkinson's Disease


Multiple Sclerosis


Ischemic Stroke



Early Clinical

Pivotal Clinical

In market

Latest News & Updates

Stay up to date

Article placeholder black
Cognito's light-and-sound therapy slows brain tissue atrophy in Alzheimer's study
Some health apps are able not just to diagnose diseases, but also to treat them
Article placeholder black
Gamma Sensory Stimulation Demonstrates Efficacy in Alzheimer Disease in New Analysis
article placeholder
With pharma still struggling in Alzheimer’s, health tech companies want a swing